{"id":131180,"date":"2023-07-25T17:52:37","date_gmt":"2023-07-25T17:52:37","guid":{"rendered":"https:\/\/organicconsumers.org\/?p=131180"},"modified":"2023-08-29T19:48:57","modified_gmt":"2023-08-29T19:48:57","slug":"bayer-slashes-outlook-as-glyphosate-demand-weakens-further-2","status":"publish","type":"post","link":"https:\/\/organicconsumers.org\/bayer-slashes-outlook-as-glyphosate-demand-weakens-further-2\/","title":{"rendered":"Bayer Slashes Outlook as Glyphosate Demand Weakens Further"},"content":{"rendered":"
July 25, 2023 | Source: Reuters<\/a> | by Ludwig Burger & Thomas Escritt<\/p>\n<\/div> July 25 (Reuters) – Further deterioration in demand for glyphosate-based weed killers led Bayer\u00a0(BAYGn.DE)<\/a>\u00a0to cut its full-year earnings outlook and announce a 2.5 billion euro ($2.8 billion) write-down on glyphosate-related assets.<\/p>\n In an unscheduled statement late on Monday, the German drugs and pesticides maker said it was projecting 2023 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, to be in a range of 11.3 billion euros ($12.5 billion) and 11.8 billion euros on a currency-adjusted basis, down from 13.5 billion euros reported for 2022.<\/p>\n